(Q48345238)

10 February 2018

title

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration (English)

1 reference

10 February 2018

1 reference

1 reference

1 reference

Oh JD

1 reference

10 February 2018

Russell DS

series ordinal

1 reference

10 February 2018

Vaughan CL

series ordinal

1 reference

10 February 2018

Chase TN

series ordinal

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

published in

Brain Research

1 reference

10 February 2018

volume

813

1 reference

10 February 2018

issue

1 reference

10 February 2018

page(s)

150-159

1 reference

10 February 2018

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Acute pharmacologic blockade of dyskinesias in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Prospects of glutamate antagonists in the therapy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Reduction of tyrosine kinase activity and protein tyrosine dephosphorylation by anoxic stimulation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Neostriatal mechanisms in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

NMDA receptor blockade reverses motor response alterations induced by levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

The basal ganglia and adaptive motor control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Protein tyrosine phosphorylation: implications for synaptic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Problems with current pharmacologic treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Glutamatergic drugs in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Src activation in the induction of long-term potentiation in CA1 hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Molecular neurobiology of drug addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

The current model of basal ganglia organization under scrutiny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Glutamate receptor modulation by protein phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

NMDA receptor and the tyrosine phosphorylation of its 2B subunit in taste learning in the rat insular cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Functional modulation of ligand-gated GABAA and NMDA receptor channels by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Neuronal circuitry and synaptic connectivity of the basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Transient ischemia differentially increases tyrosine phosphorylation of NMDA receptor subunits 2A and 2B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Regulation of NMDA receptors by tyrosine kinases and phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Tyrosine kinase inhibitors impair long-term memory formation in day-old chicks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

Effects of local connectivity on striatal function: stimulation and analysis of a model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

NMDA channel regulation by channel-associated protein tyrosine kinase Src.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

10.1016/S0006-8993(98)01049-X

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018